Received Nov 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
pregnant; Pain/soreness at injection site and feeling run down; Pain/soreness at injection site and feeling run down; This is a spontaneous report and received from Consumer or other non HCPs. An adult female patient (pregnant) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), in Oct2025 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Unknown, reaction(s): "Allergy". The following information was reported: VACCINATION SITE PAIN (non-serious), FATIGUE (non-serious) all with onset Oct2025, outcome "recovered" (Oct2025) and all described as "Pain/soreness at injection site and feeling run down"; MATERNAL EXPOSURE TIMING UNSPECIFIED (non-serious), outcome "unknown", described as "pregnant". It was unknown if therapeutic measures were taken as a result of vaccination site pain.